NO20024043L - Nye galeniske former for oral administrasjon med forlenget frigjöring av molsidomin - Google Patents

Nye galeniske former for oral administrasjon med forlenget frigjöring av molsidomin

Info

Publication number
NO20024043L
NO20024043L NO20024043A NO20024043A NO20024043L NO 20024043 L NO20024043 L NO 20024043L NO 20024043 A NO20024043 A NO 20024043A NO 20024043 A NO20024043 A NO 20024043A NO 20024043 L NO20024043 L NO 20024043L
Authority
NO
Norway
Prior art keywords
molsidomine
hours
released
angina
molsidomin
Prior art date
Application number
NO20024043A
Other languages
English (en)
Other versions
NO20024043D0 (no
NO329495B1 (no
Inventor
Josef-Michael Geczy
Original Assignee
Therabel Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therabel Pharmaceuticals Ltd filed Critical Therabel Pharmaceuticals Ltd
Publication of NO20024043D0 publication Critical patent/NO20024043D0/no
Publication of NO20024043L publication Critical patent/NO20024043L/no
Publication of NO329495B1 publication Critical patent/NO329495B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
NO20024043A 2000-02-24 2002-08-23 Galeniske former for oral administrasjon med forlenget frigjoring av molsidomin NO329495B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0002307A FR2805462B1 (fr) 2000-02-24 2000-02-24 Nouvelle forme galenique orale a liberation prolongee de la molsidomine
PCT/EP2001/002055 WO2001062256A1 (fr) 2000-02-24 2001-02-22 Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Publications (3)

Publication Number Publication Date
NO20024043D0 NO20024043D0 (no) 2002-08-23
NO20024043L true NO20024043L (no) 2002-08-23
NO329495B1 NO329495B1 (no) 2010-11-01

Family

ID=8847342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024043A NO329495B1 (no) 2000-02-24 2002-08-23 Galeniske former for oral administrasjon med forlenget frigjoring av molsidomin

Country Status (36)

Country Link
US (1) US7767227B2 (no)
EP (1) EP1265614B1 (no)
JP (1) JP4945043B2 (no)
KR (1) KR100814191B1 (no)
CN (1) CN100396284C (no)
AT (1) ATE296632T1 (no)
AU (2) AU2001240653B9 (no)
BE (1) BE1013487A3 (no)
BG (1) BG66111B1 (no)
BR (1) BRPI0108041B8 (no)
CA (1) CA2400886C (no)
CZ (1) CZ301993B6 (no)
DE (1) DE60111196T2 (no)
DZ (1) DZ3273A1 (no)
EE (1) EE05098B1 (no)
ES (1) ES2241803T3 (no)
FR (1) FR2805462B1 (no)
HK (1) HK1050138B (no)
HR (1) HRP20020692B1 (no)
HU (1) HU229799B1 (no)
IL (2) IL151205A0 (no)
IS (1) IS2446B (no)
MA (1) MA25576A1 (no)
MD (1) MD3119C2 (no)
MX (1) MXPA02008262A (no)
NO (1) NO329495B1 (no)
NZ (1) NZ520691A (no)
OA (1) OA12183A (no)
PL (1) PL201631B1 (no)
PT (1) PT1265614E (no)
RS (1) RS50291B (no)
RU (1) RU2263506C2 (no)
SK (1) SK286313B6 (no)
UA (1) UA73972C2 (no)
WO (1) WO2001062256A1 (no)
ZA (1) ZA200206042B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine
US7803402B2 (en) * 2002-07-06 2010-09-28 Sanjeev Khandelwal Pharmaceutical preparations
FR2868314B1 (fr) * 2004-04-05 2008-10-24 Therabel Pharmaceuticals Ltd Nouvelle utilisation therapeutique de la molsidomine et de ses sels pharmaceutiquement acceptables
EP2468269A1 (en) 2010-11-26 2012-06-27 Universitätsklinikum Münster Nitric oxide donors in therapy of nitric oxide deficiency-induced disturbances of cerebral microcirculation
BE1028879B1 (fr) 2020-12-11 2022-07-12 Europharmaceuticals Comprimé à libération prolongée de la molsidomine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3522191A1 (de) * 1985-06-21 1987-01-15 Cassella Ag Photostabilisierung von sydnoniminen
CN1006522B (zh) * 1986-04-30 1990-01-24 田道制药有限公司 缓放性制剂的制备方法
HU210921B (en) * 1990-03-28 1995-09-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing inclusion complexes of n-ethoxycarbonyl-3-morpholino-sydnonimine formed with cyclodextrines and pharmaceutical compositions containing them
HU211648A9 (en) * 1990-03-28 1995-12-28 Chinoin Gyogyszer Es Vegyeszet Inclusion complexes of 3-morpholino-sydnonimine or its salts or its tautomer isomer, process for the preparation thereof, and pharmaceutical compositions containing the same
DE4140192C2 (de) * 1991-12-05 1996-02-29 Alfatec Pharma Gmbh Sol-gesteuerte Thermokolloidmatrix auf Gelatinebasis für perorale Retardformen
DE59408793D1 (de) * 1993-05-11 1999-11-11 Hoechst Ag Galenische Zubereitungen von Molsidomin
WO1995001767A1 (en) * 1993-07-08 1995-01-19 Cygnus Therapeutic Systems Monolithic matrix transdermal delivery system
IT1266565B1 (it) * 1993-07-22 1997-01-09 Ct Lab Farm Srl Composizioni farmaceutiche a rilascio controllato a base di uno o piu' sali farmaceuticamente accettabili dell'acido gamma-idrossi-butirrico.
HU218280B (en) * 1994-04-26 2000-07-28 Cyclodextrin inclusion complexes containing sin-1a which are stable intheir solid state, process for their preparation and pharmaceutical compositions containing the comlexes
DE4443105C2 (de) * 1994-12-03 1997-03-13 Hoechst Ag Verfahren zur Herstellung Molsidomin-haltiger Tabletten
JPH09114680A (ja) * 1995-10-19 1997-05-02 Fuji Xerox Co Ltd シーケンス制御装置
IT1282576B1 (it) * 1996-02-06 1998-03-31 Jagotec Ag Compressa farmaceutica atta a cedere la sostanza attiva in tempi successivi e predeterminabili
PE57198A1 (es) * 1996-03-25 1998-10-10 American Home Prod Formula de liberacion prolongada
JP2002522354A (ja) * 1997-09-19 2002-07-23 シャイア ラボラトリーズ，インコーポレイテッド 固溶体ビードレット
FR2775188B1 (fr) * 1998-02-23 2001-03-09 Lipha Forme galenique a liberation immediate ou liberation prolongee administrable par voie orale comprenant un agent promoteur d'absorption et utilisation de cet agent promoteur d'absorption
FR2805462B1 (fr) * 2000-02-24 2003-08-15 Therabel Res Nouvelle forme galenique orale a liberation prolongee de la molsidomine

Also Published As

Publication number Publication date
JP2003523981A (ja) 2003-08-12
US20030045522A1 (en) 2003-03-06
KR20020081323A (ko) 2002-10-26
FR2805462A1 (fr) 2001-08-31
HRP20020692B1 (en) 2011-10-31
HUP0300607A2 (hu) 2003-08-28
PT1265614E (pt) 2005-10-31
ES2241803T3 (es) 2005-11-01
AU4065301A (en) 2001-09-03
EE200200472A (et) 2003-12-15
HK1050138B (zh) 2005-07-29
MXPA02008262A (es) 2004-04-05
HU229799B1 (en) 2014-07-28
HRP20020692A2 (en) 2004-02-29
EP1265614B1 (fr) 2005-06-01
US7767227B2 (en) 2010-08-03
CA2400886A1 (fr) 2001-08-30
DZ3273A1 (fr) 2001-08-30
SK286313B6 (en) 2008-07-07
CA2400886C (fr) 2011-04-19
MD3119C2 (ro) 2007-04-30
NO20024043D0 (no) 2002-08-23
SK12202002A3 (sk) 2002-12-03
EE05098B1 (et) 2008-12-15
HK1050138A1 (en) 2003-06-13
WO2001062256A1 (fr) 2001-08-30
CN1419451A (zh) 2003-05-21
UA73972C2 (en) 2005-10-17
BG107027A (bg) 2003-04-30
OA12183A (fr) 2006-05-09
RS50291B (sr) 2009-09-08
IS6504A (is) 2002-08-14
ATE296632T1 (de) 2005-06-15
CN100396284C (zh) 2008-06-25
CZ301993B6 (cs) 2010-09-01
PL357550A1 (en) 2004-07-26
DE60111196D1 (de) 2005-07-07
HUP0300607A3 (en) 2006-02-28
BE1013487A3 (fr) 2002-02-05
BRPI0108041B8 (pt) 2021-05-25
BG66111B1 (bg) 2011-05-31
MA25576A1 (fr) 2002-10-01
JP4945043B2 (ja) 2012-06-06
MD20020212A (en) 2002-12-31
FR2805462B1 (fr) 2003-08-15
KR100814191B1 (ko) 2008-03-17
AU2001240653B9 (en) 2005-10-27
IL151205A0 (en) 2003-04-10
IL151205A (en) 2011-01-31
ZA200206042B (en) 2003-07-29
DE60111196T2 (de) 2006-05-11
MD3119B2 (en) 2006-08-31
BR0108041A (pt) 2002-10-29
IS2446B (is) 2008-11-15
YU62202A (sh) 2006-01-16
EP1265614A1 (fr) 2002-12-18
PL201631B1 (pl) 2009-04-30
BR0108041B1 (pt) 2013-06-18
NZ520691A (en) 2004-07-30
RU2263506C2 (ru) 2005-11-10
RU2002121503A (ru) 2004-03-20
NO329495B1 (no) 2010-11-01
AU2001240653B2 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
RS115104A (en) Pramipexole once-daily dosage form
ATE333265T1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
WO2003072025A3 (en) Modified release formulations of at least one form of tramadol
RU2005115855A (ru) Композиция трамадола продлонгированного высвобождением с 24-часовым действием
HUP0203204A2 (hu) Orális adagolási forma
EA200870368A1 (ru) Антибиотические композиции с модифицированным высвобождением и способ их получения
CY1105168T1 (el) Διφασικη συνθεση με τραμαδολη
CA2415154A1 (en) Modified release formulations of selective serotonin re-uptake inhibitors
HUP0500842A2 (hu) Dronedaront tartalmazó gyógyászati készítmény parenterális adagolásra
NO20024043D0 (no) Nye galeniske former for oral administrasjon med forlenget frigjöring av molsidomin
WO2007015270A3 (en) Novel controlled release compositions of selective serotonin reuptake inhibitors
JP2004522780A5 (no)
ITMI20080798A1 (it) Composizione a rilascio modificato a base di doxofillina
JP2009507850A5 (no)
HRP20160479T1 (hr) Oralni pripravak molsidomina s produljenim otpuštanjem, namijenjen liječenju ateroskleroze
HUP0401021A2 (hu) Gepiront tartalmazó gyógyászati készítmény orális beadásra
HUP0200148A2 (hu) N-(3',4'-dimetoxi-cinnamoil)antranilsav alkalmazása szívkoszorúér-műtéttel kapcsolatos cardiovascularis események megelőzésére vagy mérséklésére

Legal Events

Date Code Title Description
MK1K Patent expired